Feedback / Questions
foralumab nasal (TZLS-401 nasal) - Tiziana Life Sci
https://www.globenewswire.com/news-release/2025/06/13/3099102/0/en/Tiziana-Life-Sciences-Expands-Phase-2-Clinical-Trial-of-Intranasal-Foralumab-with-Commencement-of-First-Patient-Dosing-at-Weill-Cornell-Multiple-Sclerosis-Center.html
Jun 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next